- Zacks•5 hours ago
Clovis Oncology, Inc. (CLVS) reported fourth-quarter 2016 loss of $1.83 per share, wider than the Zacks Consensus Estimate of a loss of $1.65.
- Zacks•23 hours ago
Momenta's (MNTA) fourth quarter results beat estimates by a wide-margin. However, the issuance of a warning letter to manufacturer Pfizer for Glatopa was disappointing.
- Business Wire•yesterdayIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Momenta Pharmaceuticals, Inc., and Encourages Investors to Contact the Firm
Khang & Khang LLP announces that it is investigating claims against Momenta Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||15.00 x 1400|
|Ask||15.10 x 1500|
|Day's Range||14.43 - 15.35|
|52 Week Range||7.86 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-11.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|